Home Newsfeeds DA Davidson Maintains Neutral on Summit Materials, Lowers Price Target to $26

DA Davidson Maintains Neutral on Summit Materials, Lowers Price Target to $26

DA Davidson analyst Brent Thielman maintains Summit Materials (NYSE:SUM) with a Neutral and lowers the price target from $33 to $26.

byBenzinga Newsdesk

July 1, 2022

1 minute read

DA Davidson analyst Brent Thielman maintains Summit Materials (NYSE:SUM) with a Neutral and lowers the price target from $33 to $26.

Cramer Compares Baidu’s ‘Ernie’ Chatbot To Struggling Nikola, Says ‘Real AI Winner’ Is Nvidia

By Shanthi Rexaline

March 16, 8:29 AM

Chinese search giant Baidu, Inc. (NASDAQ: BIDU) on Thursday announced its version of an AI chatbot named ERNIE Bot.

BIDU

BrainStorm Presents New Biomarker Analyses From NurOwn’s Phase 3 ALS Trial At The ALS ONE Research Symposium

By Benzinga Newsdesk

October 7, 12:04 PM

NurOwn® drove biomarker responses, affecting pathways related to neurodegeneration, neuroinflammation, and neuroprotection, that were consistent in participants with both advanced ALS and less advanced disease,

BCLI

Why Did Epilepsy/Seizure Focused-Marinus Pharmaceuticals Stock Hit 52-Week Low On Monday?

By Vandana Singh

April 15, 10:13 AM

Marinus Pharmaceuticals provides updates on Phase 3 RAISE trial for refractory status epilepticus treatment with IV ganaxolone. With enrollment completion expected, topline results are anticipated by summer 2024.

MRNS

BEN Holders Rejoice: PsyDex Launch Offers Exclusive Airdrop, ETH Benefits Courtesy Of BitBoy

By Jose Rodrigo Safdiye

May 30, 11:31 AM

Crypto influencer Bitboy recently unveiled PsyDex, an innovative Crypto DEX and Memecoin Launchpad set to solve the meme coins liquidity issues.

ETH

DA Davidson Maintains Neutral on Summit Materials, Lowers Price Target to $26

Related Posts

Cramer Compares Baidu’s ‘Ernie’ Chatbot To Struggling Nikola, Says ‘Real AI Winner’ Is Nvidia

BrainStorm Presents New Biomarker Analyses From NurOwn’s Phase 3 ALS Trial At The ALS ONE Research Symposium

Why Did Epilepsy/Seizure Focused-Marinus Pharmaceuticals Stock Hit 52-Week Low On Monday?

BEN Holders Rejoice: PsyDex Launch Offers Exclusive Airdrop, ETH Benefits Courtesy Of BitBoy